RYLPF News and Press, Koninklijke Philips NV From 01/30/23

January 30, 2023 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today presents its plan to create value with sustainable impact based on focused organic growth and scalable innovation, with improved execution as ...

January 30, 2023 Fourth-quarter highlights Group sales amounted to EUR 5.4 billion, with 3% comparable sales growth driven by component supply improvements, while Philips’ supply chain conditions remain challenging Comparable order intake decreased 8%, due to lower demand...

Summary GEHC is the best performing unit of GE, and now you can buy the company on its own. With a moat across multiple industries, profitability, and innovation, I believe the fundamentals of the company are rock solid. The issue is predicting where the valuation will find equilibr...

Summary Harris Associates’ 13F portfolio value decreased from $62.85B to $59.68B this quarter. They added Warner Bros. Discovery and increased Salesforce, KKR, and Oracle while decreasing Keurig Dr Pepper and Humana. The top three positions are Alphabet, Fiserv, and Amazon.co...

Summary This month I had 6 transactions. New forward dividend is approximately $1.134. Next month I am looking to add capital to the IGaming sector, CVS Health, and/or Brookfield Asset Management. I am also looking to consolidate one of my smaller positions. Octo...

Summary Philips' Sleep & Respiratory Healthcare segment is giving it a major headache. Koninklijke Philips has a past of lacking focus and proper execution. The dividend could be scrapped altogether as cash declines, outlooks have worsened, and debt has increased. ...

Koninklijke Philips N.V. (PHG) Q3 2022 Earnings Conference Call October 24, 2022 4:00 A.M. ET Company Participants Leandro Mazzoni - Head, Investor Relations Roy Jakobs - Chief Executive Officer Abhijit Bhattacharya - Chief Financial Officer Conference Call...

Summary August 31 - September 30, 2022 readers mentioned 42 equities in their comments. Some lamented bad news, so bad-news investments (rogues) mixed with (mostly) favorites. (Thus, these are ReFa/Ro.). Ten analyst-target-estimated Top-Net-Gain ReFa/Ro: ALLY, ABR, GSK, RC, OFS, I...

Summary Harris Associates’ 13F portfolio value decreased from $75.90B to $62.85B this quarter. They increased Amazon.com, Meta Platforms, and Salesforce while reducing Keurig Dr. Pepper, Humana, Regeneron Pharma, CVS Health, Constellation Brands, and General Dynamics. T...

Ave Maria Mutual Funds is a U.S. mutual fund family that takes a pro-life and pro-family approach to investing, with a proprietary screening process. We focus on good investment opportunities for the long-term. For the three months ended June 30, 2022, the total return on the Ave Mari...